Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel antiparkinsonian agent displays improved side effect profile

Feb. 26, 1998

Behavioral effects of methylene blue studied in animal models

Feb. 26, 1998

Dolasetron now available in U.S.

Feb. 25, 1998

Lead compound from ABS shows promise for neurodegenerative disorders

Feb. 25, 1998

Another market introduction for Aricept

Feb. 25, 1998

Biogen sets up Canadian office to promote local development of Avonex

Feb. 25, 1998

NOS inhibition with L-NMMA reduces CBF in humans

Feb. 25, 1998

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

Feb. 25, 1998

T Cell Sciences receives patent on new compound

Feb. 25, 1998

Apollo licenses technologies from U. of Florida

Feb. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...